The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer

BACKGROUND: Treatment for local and locoregional recurrence or second head-and-neck (H&N) cancers after previous radiotherapy is challenging, and re-irradiation carries a significantly increased risk for radiotherapy-related normal tissue toxicities and treatment failure due to a radioresistant...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiat Oncol
Main Authors: Rühle, Alexander, Sprave, Tanja, Kalckreuth, Tobias, Stoian, Raluca, Haehl, Erik, Zamboglou, Constantinos, Laszig, Roland, Knopf, Andreas, Grosu, Anca-Ligia, Nicolay, Nils H.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7164259/
https://ncbi.nlm.nih.gov/pubmed/32299456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-020-01531-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados